Music in Vein in the Intensive Care Unit

Mechanical Ventilation Clinical Trial

Official title:

Music in Vein in the Intensive Care Unit

Clinical Trial Details — Status: Active, not recruiting

Administrative data

• NCT number: NCT04291677
• Other study ID #: MUSICALCARE-ICU
• Status: Active, not recruiting
• Phase: N/A
• Start date: January 2017
• Est. completion date: June 2021

Study information

• Verified date: February 2021
• Source: Hospital Universitario 12 de Octubre
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Patients admitted to the Intensive Care Units (ICU) that receive mechanical ventilation need high dose sedative and analgesic medication that may have side effects. Despite this, many of them also experience anxiety and added stress. Musical intervention is a useful non-pharmacological tool without adverse effects safe and easy to provide for patients with mechanical ventilation admitted to the Intensive Care Units. Its use reduces the use and dose of sedatives, reduces stress and environmental noise. It should be considered in the measures of control of anxiety and noise in the ICU. The objective of the study is to analyze whether the implementation of a musical intervention can be an effective non-pharmacological intervention in the therapy of patients undergoing mechanical ventilation admitted to an Intensive Care Unit of a High Complexity Hospital.

Description:

This is a prospective, randomized clinical study will be developed in the three Units of Intensive Care of the Intensive Medicine Service of the 12 de Octubre Universitarian Hospital. All adult patients admitted to the ICU with requirements for mechanical ventilation and in which the unit's pseudoanalgesia protocol is implemented and having signed your legal representative informed consent to participate in the study will be included. The Patients admitted to the ICU with predictable survival less than 48 hours; those who are not submitted to mechanical ventilation and those whose Legal representative refuses to sign the informed consent wouldn't participate. The patients will be randomized in two groups: Group A: Intervention group in which musical intervention will be applied between the first and the third day of mechanical ventilation. Group B: Control group with standard treatment without musical intervention. Live music will be applied every day of the week by professional musicians of the non-profit association Music in Vena (MeV) until mechanical ventilation is removed. There will be sessions of 30 minutes a day. The execution time will be from 13-13:30 hours, and the family will be allowed to participate. The type of music will be classical to be determined by musicians. The participants will be followed for the duration invasive mechanical ventilation. The Investigators of this project ensure that the principalities ethics for medical research in beings humans of the HELSINKI DECLARATION OF THE WORLD MEDICAL ASSOCIATION have been adapted. MUSICALCARE-ICU has been approved by the Ethics Committee of the 12 de Octubre Universitarian Hospital. The legal representative must give written informed consent to participate in this study.

Recruitment information / eligibility

• Status: Active, not recruiting
• Enrollment: 200
• Est. completion date: June 2021
• Est. primary completion date: June 2021
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years to 100 Years

Eligibility

Inclusion Criteria:

• Adult patients admitted to the ICU with requirements for mechanical ventilation and in which the unit's pseudoanalgesia protocol is implemented.
• A legal representative informed consent to participate in the study has to be signed.

Exclusion Criteria:

• Patients admitted to the ICU with predictable survival less than 48 hours.
• Patients who are not subjected to mechanical ventilation.
• Patients whose Legal representative refuses to sign the informed consent.

Related Conditions & MeSH terms

• Mechanical Ventilation

Intervention

Other:
• intervention musical
Intervention group in which musical intervention will be applied the first or third day of mechanical ventilation.
• Without intervention musical
Control group with standard treatment without musical intervention.

Locations

Country	Name	City	State
Spain	Hospital Universitario 12 de Octubre	Madrid

Sponsors (1)

Lead Sponsor	Collaborator
Juan Carlos Montejo González

Country where clinical trial is conducted

Spain, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Total and extra pseudoanalgesia requirements change.	Change of the anxiety and pain level in patients with invasive mechanical ventilation with music therapy.	It will be analyzed at baseline, at the end of the musical intervention, at 30 minutes, 60 minutes and at 8 hours after the intervention.
Secondary	Change of Heart rate.	Change of the heart rate registered in electrocardiogram in patients with invasive mechanical ventilation with music therapy.	It will be analyzed at baseline, at the end of the musical intervention, at 30 minutes, 60 minutes and at 8 hours after the intervention.
Secondary	Change of systolic blood pressure; diastolic blood pressure and mean blood pressure.	Change systolic blood pressure; diastolic blood pressure and average blood pressure.	It will be analyzed at baseline, at the end of the musical intervention, at 30 minutes, 60 minutes and at 8 hours after the intervention.
Secondary	Change vasoactive drug requirements.	Percentage of patients who experience a change of the vasoactive drug requirements in patients with invasive mechanical ventilation with music therapy.	It will be analyzed at baseline, at the end of the musical intervention, at 30 minutes, 60 minutes and at 8 hours after the intervention.
Secondary	Blood glucose control.	Percentage of patients who normalize blood glucose levels (range 70-110 milligrams/deciliter).	It will be analyzed at baseline, at the end of the musical intervention, at 30 minutes, 60 minutes and at 8 hours after the intervention.
Secondary	Change insulin requirements.	Percentage of patients who change insulin requirements measured as International Unit per day (IU/day).	It will be analyzed at baseline, at the end of the musical intervention, at 30 minutes, 60 minutes and at 8 hours after the intervention.
Secondary	Change cortisol and growth hormone level.	Change serum levels biomarkers (cortisol and growth hormone level) in patients with invasive mechanical ventilation with music therapy.	It will be performed at 9 hours, prior to the implementation of the musical intervention, and at 30 minutes after the end of the intervention on days 1, 3, 7 and 10.
Secondary	Change the stay in the Intensive Care Unit (ICU)	Change in mechanical ventilation time in patients with musical intervention reduces ICU stay.	At 90 days
Secondary	Quality of Life (HRQoL) according to Karnofsky's index.	Change in the Quality of Life (QoL) will be measured using the Karnofsky Performance Status other method to assess the functional status of a patient. The Karnofsky index, between 100 and 0.; 100-Normal, no complaints; no evidence of disease. 90-Able to carry on normal activity; minor signs or symptoms of disease. 80-Normal activity with effort, some signs or symptoms of disease. 70-Cares for self but unable to carry on normal activity or to do active work. 60-Requires occasional assistance but is able to care for most of personal needs.; 50-Requires considerable assistance and frequent medical care. 40-Disabled; requires special care and assistance. 30-Severely disabled; hospitalization is indicated although death not imminent. 20-Very ill; hospitalization and active supportive care necessary. 10-Moribund 0-Dead	At 90 days
Secondary	The overall Health related Quality of Life (HRQoL) of patients with requirements for mechanical ventilation will be measured using a patient self rating questionnaire.	Change in the Quality of Life (QoL) will be measured using the Eastern Cooperative Oncology Group (ECOG) Scale of Performance Status who describes a patient's level of functioning in terms of their ability to care for themselves, daily activity, and physical ability (walking, working, etc.).; Grade 0: Fully active, able to carry on all pre-disease performance without restriction.; Grade 1: Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work.; Grade 2: Ambulatory and capable of all selfcare but unable to carry out any work activities; up and about more than 50% of waking hours.; Grade 3: Capable of only limited selfcare; confined to bed or chair more than 50% of waking hours Grade 4: Completely disabled; cannot carry on any selfcare; totally confined to bed or chair Grade 5: Dead.	At 90 days